ADENOSQUAMOUS CARCINOMA OF THE PANCREAS

Clinical trials for ADENOSQUAMOUS CARCINOMA OF THE PANCREAS explained in plain language.

Never miss a new study

Get alerted when new ADENOSQUAMOUS CARCINOMA OF THE PANCREAS trials appear

Sign up with your email to follow new studies for ADENOSQUAMOUS CARCINOMA OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Three-Drug immune attack on deadly pancreatic cancer

Disease control Terminated

This study is testing whether a combination of three immunotherapy drugs can help control metastatic pancreatic cancer after initial chemotherapy. The trial compares two different treatment approaches to see which works better at keeping the cancer from growing. About 46 people w…

Matched conditions: ADENOSQUAMOUS CARCINOMA OF THE PANCREAS

Phase: PHASE1, PHASE2 • Sponsor: James Cleary, MD, PhD • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

ADENOSQUAMOUS CARCINOMA OF THE PANCREAS

Get alerted when new ADENOSQUAMOUS CARCINOMA OF THE PANCREAS trials appear

Three-Drug immune attack on deadly pancreatic cancer